HYDROFARM HOLDINGS GROUP, INC. annual report, FY2023

Hydrofarm Holdings Group, Inc. — FY2023 Form 10-K

Reporting period: Fiscal year ended December 31, 2023. This is an annual report; the supplied filing does not provide standalone fourth-quarter results. Hydrofarm manufactures and distributes controlled-environment agriculture equipment and supplies, primarily in the United States and Canada, through more than 2,000 wholesale customer accounts. Management says agricultural oversupply—particularly in cannabis—has reduced cultivation activity and demand.

Financial performance

MetricFY2023FY2022
Net sales$226.6 million$344.5 million
Gross profit / margin$37.6 million / 16.6%$29.3 million / 8.5%
SG&A$87.3 million$118.6 million
Operating loss$49.7 million$281.6 million
Net loss$64.8 million$285.4 million
Net loss per diluted share$1.42$6.35
Cash from operations$7.0 million$22.0 million
Capital expenditures$4.2 million$8.2 million
  • Sales declined 34.2% year over year: product volume fell 32%, with price and mix down 2%. Management attributes the volume decline mainly to cannabis-market oversupply. Sales mix shifted toward lower-priced consumables, and the company lowered prices on some products.
  • Gross margin improved to 16.6% from 8.5%, despite lower sales. The filing cites lower inventory charges than in 2022, reduced acquisition and integration costs, a higher proportion of proprietary-brand sales, lower freight costs and productivity improvements; restructuring charges partly offset those benefits.
  • SG&A fell 26.4%, reflecting cost reductions and lower amortization and depreciation, among other items. Nevertheless, SG&A was 38.5% of sales.
  • FY2023 net loss included no impairment charge. FY2022 included $189.6 million of goodwill impairment and $2.6 million of note-receivable impairment.
  • Operating cash flow was $7.0 million, down from $22.0 million. Inventory reductions provided a $26.1 million working-capital cash inflow in 2023. Cash interest paid increased to $13.1 million from $9.6 million.

Financial position and liquidity

  • At December 31, 2023, cash and cash equivalents were $30.3 million, current assets $128.1 million and current liabilities $37.7 million. Inventory was $75.4 million, down from $111.4 million a year earlier.
  • Term Loan principal outstanding was $122.5 million; the balance-sheet carrying amount of total debt was $118.4 million, net of unamortized discount and financing costs. The Term Loan matures October 2028, bears variable rates, and had an 11.55% effective interest rate in 2023. A 100-basis-point rate increase would add an estimated $1.1 million of annual interest expense.
  • The $55 million revolving facility had no borrowings at year-end; approximately $22 million was available before a minimum fixed-charge coverage covenant would apply. The facility matures June 2026. The company reported compliance with debt covenants at year-end.
  • Management believes cash, operating cash flow and revolver availability should support operations, debt service, capital expenditures, leases and working capital for the next 12 months, but cautions that future cash generation and borrowing availability are not assured.
  • Estimated 2024 cash requirements include $3.0 million of debt principal, $14.8 million of interest, $10.4 million of operating-lease payments, $1.4 million of finance-lease payments and $2.2 million subject to the Term Loan’s sale-leaseback reinvestment provision.

Material changes, outlook and notable items

  • The company recorded $11.3 million of restructuring charges in 2023, including $9.7 million of non-cash charges, primarily inventory write-downs and asset dispositions. A second restructuring phase includes U.S. manufacturing consolidations and reduced facility space. Management estimates further charges may exceed $2.0 million, including cash costs exceeding $1.0 million, and anticipates approximately $1.5 million in annualized savings. Actual costs and savings may differ.
  • In January 2023, Hydrofarm received $8.6 million in a Eugene, Oregon sale-leaseback and entered a 15-year lease. The filing accounts for it as a failed sale-leaseback, retaining the assets and recording a financial liability.
  • Management provided no specific revenue or earnings guidance. It intends to focus on cost reduction, productivity, proprietary brands and expansion in food, floral and consumer-gardening markets. Sales are typically seasonally stronger in the first three quarters, though management says recent market weakness has made patterns less consistent.
  • The business remains exposed to cannabis-industry demand and uncertain U.S. cannabis regulation, including the federal-state legal conflict. Credit agreements prohibit direct sales to cannabis growers where cannabis sales and use are not lawful under applicable law.
  • Other key risks include further demand weakness, inventory obsolescence, potential asset impairments, variable-rate debt, supplier concentration, long-term leases, raw-material and freight costs, weather impacts on peat harvesting, and restructuring execution. Intangible assets were $275.9 million at year-end; goodwill had been fully impaired in 2022.
  • The filing reports no known legal proceedings expected to have a material adverse effect. The auditor issued an unmodified opinion on the financial statements and identified inventory valuation as a critical audit matter. Management concluded disclosure controls and internal control over financial reporting were effective; the auditor was not required to attest to internal-control effectiveness.

Important facts for investors to verify

  • Whether sales volumes and customer demand stabilize, particularly in cannabis-related end markets, and whether growth in other CEA markets offsets weakness.
  • Whether improved gross margin and lower operating costs persist at current sales levels, and whether restructuring delivers its estimated savings without substantial additional charges.
  • Inventory quality and realizable value, including the assumptions underlying the $10.1 million obsolescence allowance and any remaining exposure to additional write-downs.
  • Liquidity and debt-service capacity under continued operating losses: monitor operating cash flow, available revolver borrowing, covenant headroom, floating interest rates and the 2024 sale-leaseback reinvestment/prepayment requirements.
  • Whether the company can avoid further impairments to its substantial intangible-asset balance and manage lease obligations and manufacturing-facility consolidation costs.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.